CD8A and neoplasm: Major findings were the significantly reduced lymphocyte count already at baseline for untreated patients compared to healthy individuals, the impact of RT treatment to enhance the expression of CD8+ effector memory cells, and finally the differential response of myeloid populations, with canonical, tumor-promoting myelocytes becoming less abundant following, in favor of non-canonical CD8+ recruiting cells.